TIAA FSB’s Fate Therapeutics FATE Stock Holding History

TIAA FSB’s Portfolio FATE Stock Details FATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$83.7K	Hold	17,592	–	–	﹤0.01%	564
2023 Q1	$100K	Hold	17,592	–	–	﹤0.01%	558
2022 Q4	$178K	Hold	17,592	–	–	﹤0.01%	547
2022 Q3	$394K	Hold	17,592	–	–	﹤0.01%	429
2022 Q2	$436K	Hold	17,592	–	–	﹤0.01%	430
2022 Q1	$682K	Hold	17,592	–	–	﹤0.01%	328
2021 Q4	$1.03M	Hold	17,592	–	–	﹤0.01%	305
2021 Q3	$1.04M	Hold	17,592	–	–	﹤0.01%	303
2021 Q2	$1.53M	Hold	17,592	–	–	0.01%	286
2021 Q1	$1.45M	Hold	17,592	–	–	0.01%	279
2020 Q4	$1.6M	Sell	17,592 -2,500	-12%	-$155K	0.01%	265
2020 Q3	$803K	Hold	20,092	–	–	﹤0.01%	253
2020 Q2	$689K	Hold	20,092	–	–	﹤0.01%	255
2020 Q1	$446K	Hold	20,092	–	–	﹤0.01%	250
2019 Q4	$393K	Buy	+20,092	New	+$319K	﹤0.01%	281

Other funds holding FATE

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

TIAA FSB's FATE Position: Q2 2023 in Review

TIAA FSB held its Fate Therapeutics (FATE) position steady in Q2 2023 at 17,592 shares worth $83.7K. The position accounts for ﹤0.01% of the portfolio, ranked #564.

TIAA FSB first reported a position in FATE in Q4 2019 and has held it in 15 quarters since. The position peaked at $1.6M in Q4 2020. 188 funds tracked by Wall St. Rank hold FATE as of Q2 2023.

TIAA FSB held 17,592 shares of Fate Therapeutics worth $83.7K as of Q2 2023.
TIAA FSB left its Fate Therapeutics share count unchanged in Q2 2023.
Fate Therapeutics made up ﹤0.01% of TIAA FSB's portfolio in Q2 2023, its #564 holding.
TIAA FSB first reported a position in Fate Therapeutics in Q4 2019 and has held it in 15 quarters since.
TIAA FSB's Fate Therapeutics position peaked at $1.6M in Q4 2020.
188 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2023.

Based on TIAA FSB's 13F filing for Q2 2023, filed 31 Jul 2023.